• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go!一种用于危重症患者曲霉病管理的经验证的临床方法:准备,稳定,行动!
Crit Care. 2006;10(2):132. doi: 10.1186/cc4860.
2
Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study.慢性阻塞性肺疾病重症患者的疑似侵袭性肺曲霉病:一项匹配队列研究
Crit Care. 2015 Dec 3;19:421. doi: 10.1186/s13054-015-1140-1.
3
Aspergillus infections in the critically ill.危重症患者的曲霉菌感染。
Proc Am Thorac Soc. 2010 May;7(3):204-9. doi: 10.1513/pats.200906-050AL.
4
Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.危重症患者真菌性呼吸道感染的流行病学、诊断与治疗
Rev Esp Quimioter. 2013 Jun;26(2):173-88.
5
Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series.失代偿期肝硬化患者的侵袭性肺曲霉病:病例系列
BMC Gastroenterol. 2007 Jan 31;7:2. doi: 10.1186/1471-230X-7-2.
6
Invasive Aspergillosis: Current Strategies for Diagnosis and Management.侵袭性曲霉病:当前的诊断与管理策略
Infect Dis Clin North Am. 2016 Mar;30(1):125-42. doi: 10.1016/j.idc.2015.10.015.
7
Elderly versus nonelderly patients with invasive aspergillosis in the ICU: a comparison and risk factor analysis for mortality from the AspICU cohort.重症监护病房中侵袭性曲霉病的老年患者与非老年患者:来自AspICU队列的死亡率比较及危险因素分析
Med Mycol. 2018 Aug 1;56(6):668-678. doi: 10.1093/mmy/myx117.
8
How to manage aspergillosis in non-neutropenic intensive care unit patients.如何管理非中性粒细胞减少的重症监护病房患者的曲霉病。
Crit Care. 2014 Jul 25;18(4):458. doi: 10.1186/s13054-014-0458-4.
9
Aspergillosis in the 'nonimmunocompromised' host.非免疫功能低下宿主中的曲霉菌病。
Immunol Invest. 2011;40(7-8):751-66. doi: 10.3109/08820139.2011.614307.
10
Evolving strategies in the management of aspergillosis.曲霉病管理中的不断演变的策略。
Expert Opin Pharmacother. 2008 Feb;9(2):193-209. doi: 10.1517/14656566.9.2.193.

引用本文的文献

1
Performance of Diagnostic Algorithms in Patients With Invasive Pulmonary Aspergillosis.侵袭性肺曲霉病患者诊断算法的性能
Clin Infect Dis. 2025 Jun 4;80(5):1080-1087. doi: 10.1093/cid/ciae633.
2
Indoor airborne fungal pollution in newborn units in Turkey.土耳其新生儿病房的室内空气真菌污染
Environ Monit Assess. 2017 Jul;189(7):362. doi: 10.1007/s10661-017-6051-y. Epub 2017 Jun 30.
3
Invasive pulmonary aspergillosis in an immunocompetent patient with severe dengue fever.一名免疫功能正常的重症登革热患者发生侵袭性肺曲霉病。
Indian J Crit Care Med. 2014 May;18(5):323-5. doi: 10.4103/0972-5229.132505.
4
Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection?非免疫功能低下患者的呼吸道样本中反复分离出烟曲霉:定植还是感染?
BMC Infect Dis. 2012 Nov 12;12:295. doi: 10.1186/1471-2334-12-295.
5
Pulmonary aspergillosis: a clinical review.肺曲霉病:临床综述。
Eur Respir Rev. 2011 Sep 1;20(121):156-74. doi: 10.1183/09059180.00001011.
6
Patients at high risk of invasive fungal infections: when and how to treat.侵袭性真菌感染高危患者:何时以及如何进行治疗。
Drugs. 2008;68(14):1941-62. doi: 10.2165/00003495-200868140-00002.

本文引用的文献

1
Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients.重症患者呼吸道样本中分离出曲霉菌的临床相关性。
Crit Care. 2006 Feb;10(1):R31. doi: 10.1186/cc4823.
2
Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome.重症患者呼吸道曲霉菌属的分离:危险因素、临床表现及预后
Crit Care. 2005 Jun;9(3):R191-9. doi: 10.1186/cc3488. Epub 2005 Mar 11.
3
Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital.烟曲霉引起的工作量及该微生物在综合医院微生物实验室中的意义。
J Clin Microbiol. 2005 May;43(5):2075-9. doi: 10.1128/JCM.43.5.2075-2079.2005.
4
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.卡泊芬净治疗对传统抗真菌治疗难治或不耐受的侵袭性曲霉病患者的疗效和安全性。
Clin Infect Dis. 2004 Dec 1;39(11):1563-71. doi: 10.1086/423381. Epub 2004 Nov 9.
5
Invasive aspergillosis in critically ill patients without malignancy.无恶性肿瘤的重症患者中的侵袭性曲霉病
Am J Respir Crit Care Med. 2004 Sep 15;170(6):621-5. doi: 10.1164/rccm.200401-093OC. Epub 2004 Jun 30.
6
Immunoparalysis as a cause for invasive aspergillosis?免疫麻痹是侵袭性曲霉病的一个病因?
Intensive Care Med. 2003 Nov;29(11):2068-71. doi: 10.1007/s00134-003-1778-z. Epub 2003 May 24.
7
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.伏立康唑与两性霉素B用于侵袭性曲霉病的初始治疗比较
N Engl J Med. 2002 Aug 8;347(6):408-15. doi: 10.1056/NEJMoa020191.
8
Aspergillus species isolated from clinical specimens: suggested clinical and microbiological criteria to determine significance.从临床标本中分离出的曲霉菌种:确定其意义的建议临床和微生物学标准。
Clin Microbiol Infect. 1998 Feb;4(12):710-716. doi: 10.1111/j.1469-0691.1998.tb00656.x.
9
Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study.从医院供水系统中分离出的致病性曲霉菌种:一项为期3年的前瞻性研究。
Clin Infect Dis. 2002 Mar 15;34(6):780-9. doi: 10.1086/338958. Epub 2002 Feb 11.
10
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.定义癌症和造血干细胞移植免疫受损患者中的机会性侵袭性真菌感染:一项国际共识。
Clin Infect Dis. 2002 Jan 1;34(1):7-14. doi: 10.1086/323335. Epub 2001 Nov 26.

一种用于危重症患者曲霉病管理的经验证的临床方法:准备,稳定,行动!

A validated clinical approach for the management of aspergillosis in critically ill patients: ready, steady, go!

作者信息

Garnacho-Montero Jose, Amaya-Villar Rosario

机构信息

Intensive Care Unit, Hospital Universitario Virgen del Rocío, Sevilla, Spain.

出版信息

Crit Care. 2006;10(2):132. doi: 10.1186/cc4860.

DOI:10.1186/cc4860
PMID:16584528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1550917/
Abstract

The clinical relevance of recovering Aspergillus species in intensive care unit patients is unknown. Diagnosis of invasive pulmonary aspergillosis is extremely difficult because there are no specific tests sensitive enough to detect it. The rapidly fatal prognosis of this infection without treatment justifies early antifungal therapy. A clinical algorithm may aid clinicians to manage critically ill patients from whose respiratory specimens Aspergillus spp. have been isolated. This new tool needs to be validated in a large cohort of patients before it can be recommended.

摘要

在重症监护病房患者中分离出曲霉菌属的临床相关性尚不清楚。侵袭性肺曲霉病的诊断极其困难,因为没有足够敏感的特异性检测方法来检测它。这种感染若不治疗,预后迅速致命,这证明了早期抗真菌治疗的合理性。一种临床算法可能有助于临床医生管理从其呼吸道标本中分离出曲霉菌属的重症患者。在推荐使用这个新工具之前,需要在大量患者队列中对其进行验证。